| Autor: |
Luisi S; Obstetrics and Gynecology Unit, Department of Pediatrics, Gynecology, and Reproductive Medicine, University of Siena, 53100 Siena, Italy., Ciani V, Gabbanini M, Sollazzi S, Torricelli M, Calonaci F, Petraglia F |
| Jazyk: |
angličtina |
| Zdroj: |
International journal of endocrinology [Int J Endocrinol] 2009; Vol. 2009, pp. 476897. Date of Electronic Publication: 2009 Jul 28. |
| DOI: |
10.1155/2009/476897 |
| Abstrakt: |
Following myomectomy the rate of fertility is restored and pregnancy may be attempted with a good outcome. In the present study a 3 month treatment with OCs in a group of women after a myomectomy was evaluated. The drug compliance and side effects, the benefits of OC in order to reduce symptoms, to increase post-surgical hemoglobin levels and to avoid an early pregnancy after myomectomy were analyzed. A group of women (n = 55) each with myoma >/=5 cm was recruited: they presented menorrhagia, pelvic pain, dyspareunia and dysmenorrhae. After laparotomic myomectomy the women were divided into 3 groups. Group 1: women (n = 16) treated with pill A (15 mcg of ethynilestradiol + 60 mcg of gestodene); group 2: women (n = 23) treated with pill B (20 mcg of ethynilestradiol + 100 mcg of levonorgestrel); group 3: women (n = 16) treated with a placebo (oral calcium). After three months from myomectomy and treatment patients in each group reported a reduced menorrhagia, dismenorrhea and pelvic pain. Serum haemoglobin levels increased in all women (P < .05). No pregnancy occurred in any group and the compliance was good. A post surgery treatment by using oral contraceptives guarentees pregnancy prevention, associated with reduction of pain, and improvement of haematologic conditions. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Plný text